Improving care for HIV and cancer in Zimbabwe
Part of Cancer clinical trials.
This study tests a program to help people living with HIV and a new cancer diagnosis stay engaged in their treatment. It is based at Parirenyatwa Hospital in Zimbabwe.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You are a patient at Parirenyatwa Hospital Radiotherapy Centre.
- You are starting treatment for a newly diagnosed cancer.
- You have HIV.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a program to help women with cervical cancer and HIV feel more empowered and less judged by stigma. It takes place at the Cancer Disease Hospital in Zambia and offers support in your preferred language.
This study tests ways to help people living with HIV in Indonesia stay engaged in their care. It may help you if you want extra support to keep up with your appointments and treatment.
This study tests whether getting HIV care through a community program is as helpful as going to a clinic for people who just found out they have HIV. It looks at how well they stay in care and take their medicine.
This study tests a low-barrier, mobile HIV care program designed with input from patients and other stakeholders to help people stay engaged in care and reach an undetectable viral load. It may help if you’re having trouble keeping regular HIV appointments or staying on treatment.
This study tests whether a trained peer mentor (someone living with HIV) can help men get back on track with their HIV care and medication. If you've fallen behind on clinic visits, this program offers personalized support to reconnect you with treatment.
This trial uses health records to learn how people in Zambia access HIV care and treatments. It may help improve future HIV support and treatment planning.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.